| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3232581 | F | Antiviral activity against Herpes simplex virus type 1 infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically | Human alphaherpesvirus 1 | 7 | ALA3227966 | organism-based format | Scientific Literature | |
| 2. | ALA3232582 | F | Antiviral activity against Vaccinia virus infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically | Vaccinia virus | 6 | ALA3227966 | organism-based format | Scientific Literature | |
| 3. | ALA3232583 | F | Antiviral activity against rhinovirus type 13 infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically | Human rhinovirus A13 | 4 | ALA3227966 | cell-based format | Scientific Literature | |
| 4. | ALA3232584 | F | Antiviral activity against Myxoma virus infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically | Myxoma virus | 6 | ALA3227966 | cell-based format | Scientific Literature | |
| 5. | ALA3232585 | F | Antiviral activity against Pseudorabies virus infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically | Suid alphaherpesvirus 1 | 6 | ALA3227966 | organism-based format | Scientific Literature | |
| 6. | ALA3232586 | F | Antiviral activity against Herpes simplex virus type 1 infected in Swiss albino mouse assessed as increase in mouse survival at 0.14 mg/kg, ic single dose after 6 hrs of infection relative to control | Human alphaherpesvirus 1 | 3 | ALA3227966 | organism-based format | Scientific Literature | |
| 7. | ALA3232587 | F | Antiviral activity against Herpes simplex virus type 1 infected in Swiss albino mouse assessed as increase in mouse survival at 0.033 mg/kg, ic single dose after 6 hrs of infection relative to control | Human alphaherpesvirus 1 | 3 | ALA3227966 | organism-based format | Scientific Literature | |
| 8. | ALA3232588 | F | Antitumor activity against mouse L1210 cells allografted in BDF/1 mouse assessed as mouse survival at 600 mg/kg, ip qd treated 24 hrs after tumor implantation relative to control | Mus musculus | 3 | ALA3227966 | organism-based format | Scientific Literature | |
| 9. | ALA3232590 | F | Antitumor activity against mouse L1210 cells allografted in BDF/1 mouse assessed as tumor weight reduction on day 5 at 600 mg/kg, ip qd treated 24 hrs after tumor implantation relative to control | Mus musculus | 3 | ALA3227966 | organism-based format | Scientific Literature | |
| 10. | ALA3232593 | F | Antitumor activity against mouse L1210 cells allografted in BDF/1 mouse assessed as mouse survival upto 60 days at 600 mg/kg, ip qd treated 24 hrs after tumor implantation relative to control | Mus musculus | 3 | ALA3227966 | organism-based format | Scientific Literature | |
| 11. | ALA3232594 | F | Antitumor activity against mouse L1210 cells allografted in BDF/1 mouse assessed as number of cures at 600 mg/kg, ip qd treated 24 hrs after tumor implantation relative to control | Mus musculus | 3 | ALA3227966 | organism-based format | Scientific Literature | |
| 12. | ALA3231154 | F | Antitumor activity against mouse L1210 cells allografted in BDF/1 mouse assessed as increase in life span at 600 mg/kg, ip qd treated 24 hrs after tumor implantation relative to control | Mus musculus | 1 | ALA3227966 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!